Mechanical Debridement Verus Radiofrequency-Based Debridement to Treat Articular Cartilage Lesions With Partial Meniscectomy in the Knee (ACT)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate changes in clinical and imaging outcomes following arthroscopic treatment of a single medial femoral chondral lesion plus partial medial meniscectomy by Radiofrequency-Based debridement or Mechanical Debridement in subjects ≥ eighteen (18) years of age.
| Condition | Intervention |
|---|---|
|
Chondral Lesion Plus Partial Medial Meniscectomy |
Device: Mechanical Debridement (Mechanical Shaver) Device: Radiofrequency-Based Debridement |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | A Prospective, Double Blinded, Multi-Center, Randomized, Controlled Trial to Evaluate Mechanical Debridement vs. Radiofrequency-Based Debridement in the Treatment of Articular Cartilage Lesions |
- Knee and Osteoarthritis Outcomes Scores (KOOS) [ Time Frame: 52 Weeks ] [ Designated as safety issue: No ]Change in Knee and Osteoarthritis Outcomes Scores (KOOS) scores post-operative compared to baseline
- International Knee Documentation(IKDC)Subjective Knee Evaluation Form [ Time Frame: Screening/Baseline, Week 6, 12, 24, 36, 52 and 104 ] [ Designated as safety issue: No ]Change in International Knee Documentation (IKDC) scores from post-operative compared to baseline
- International Knee Documentation Committee (IKDC)Knee Examination Form score [ Time Frame: Weeks 6, 12, 24, 36 52, and 104 ] [ Designated as safety issue: No ]Change in International Knee Documentation Committee (IKDC) Knee Examination Form scores from baseline
- Change in Knee and Osteoarthritis Outcomes Scores (KOOS) scores [ Time Frame: Weeks 6, 12, 24, 36 and 104 ] [ Designated as safety issue: No ]Change in KOOS scores from baseline
- Visual Analogue Scale, (VAS) Knee Pain [ Time Frame: Day 10, week 6, 12, 24, 36, 52 and 104 ] [ Designated as safety issue: No ]the change from baseline
- SF-12 [ Time Frame: Weeks 6, 12, 24, 36, 52 and 104 ] [ Designated as safety issue: No ]Change in SF-12 scores from baseline
- EQ-5D-5L [ Time Frame: Day 10, weeks 6, 12, 24, 36, 52 and 104 ] [ Designated as safety issue: No ]Change in EQ-5D-5L scores from baseline
- Magnetic Resonance Imaging (MRI) [ Time Frame: Day 10, weeks 52 and 104 ] [ Designated as safety issue: No ]MRI assessments at Day 10, Weeks 52 and 104
- Subject Satisfaction [ Time Frame: Weeks 52 and 104 ] [ Designated as safety issue: No ]Subject Satisfaction at Weeks 52 and 104
| Estimated Enrollment: | 106 |
| Study Start Date: | March 2013 |
| Estimated Primary Completion Date: | March 2015 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Mechanical Debridement (Mechanical Shaver)
Mechanical shaver that removes areas of damaged tissue
|
Device: Mechanical Debridement (Mechanical Shaver)
mechanical shaver that removes areas of damaged tissue
Other Name: Mechanical Shaver
|
|
Active Comparator: Radiofrequency-based Debridement
Electrical energy that removes areas of damaged tissue (Coblation®)
|
Device: Radiofrequency-Based Debridement
Electrical energy that removes areas of damaged tissue (Coblation®)
Other Name: Paragon® T2™ ICW wand
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Subjects MUST meet ALL of the following criteria to be included in the study:
- Given written informed consent on the IRB/REB approved Consent Form specific to the study, prior to study participation
- Is male or non pregnant female ≥ eighteen (18) years of age
Arthroscopic confirmation of a lesion requiring treatment meeting the following parameters:
- Single, treatable chondral lesion, localized to the medial femoral condyle,
- ICRS Grade 3A,
- < 4cm2 in size
- MRI within past 6 months confirming presence of a medial femoral chondral lesion and medial meniscal tear requiring a partial meniscectomy
- Must present with pain in the index knee of moderate or severe (> 30 mm) as measured by the VAS
- Must be able to understand English (written and oral)
- Must be available to come to all study related visits and is physically and mentally willing and able to comply with all post-operative evaluations
Must be in general good health (as determined by the Investigator) based on screening assessments and medical history
-
Exclusion Criteria:
Subjects will be excluded from the study, if they meet ANY one (1) of the following criteria:
- Body Mass Index (BMI) > 35
- Requires bilateral knee surgery
Any of the following conditions:
- active joint infections
- is immunocompromised, has Sickle Cell disease, has a primary bone disease (e.g., Paget's disease) or disorders that may adversely affect the healing process, or is terminally ill
- inflammatory rheumatoid arthritis or other systemic inflammatory arthritis (i.e., gout)
- metastatic and/or neoplastic disease
- infectious, highly communicable diseases (e.g., active tuberculosis or active hepatitis)
- coagulation disorder or patient is receiving anti-coagulants
- documented evidence of a history (e.g. liver testing) of drug/alcohol abuse within the 12 months prior to screening for study entry
- diagnosed with a behavioral condition which could affect their ability to accurately comply with the study (e.g. developmental delay, attention deficit disorder, and autism)
Any of the following conditions in the index limb or joint:
- Grade III or greater osteoarthritis as determined by AP radiograph (Kellgren-Lawrence classification)
- drug therapy with systemic steroid therapy, steroid intra-articular therapy or intra-articular hyaluronic acid therapy within 6 months of enrollment into this study
- osteomyelitis, septicemia, or other infections that may spread to other areas of the body
- fractures, osteocysts or osteolysis
- recurrent patellar instability (e.g., subluxation or dislocation)
- severe Varus or Valgus knee deformities
- tear of the lateral meniscus
- avascular necrosis
- synovial disorders (e.g., pigmented villanodular synovitis)
- previous total or partial meniscectomy
- requires reconstruction or replacement of medial or lateral meniscus
- knee instability, malalignment, or patellar tracking dysfunction
- prior treatment for cartilage repair, including but not limited to ACI, Mosaicplasty and/or marrow stimulation procedures
- prior knee tendon and/or ligament repair or patellar surgery within the past 6 months
Any of the following conditions in the contralateral limb or joint:
- greater than minimal abnormality as shown by clinical exam and/or imaging
- scheduled or to be scheduled for surgery over the course of this study
- involvement causing abnormal ambulation and non-compliance with post-operative rehabilitation guideline
- The subject has implanted metallic devices (insulin pumps, nerve stimulators, etc), medically implanted clips or other electronically, magnetically or mechanically activated implants that would contraindicate undergoing an MRI scan of the knee
- The subject has claustrophobia that would inhibit their ability to undergo an MRI scan of the index knee
- Receiving prescription narcotic pain medication for conditions unrelated to the index knee condition
- Cardiac pacemaker or other electronic implant(s)
- Pregnant and/or intending to become pregnant during this study period
- Participated in a clinical study within 6 months prior to surgery, or who is currently participating in another clinical study.
- Is a prisoner, or is known or suspected to be transient
- Is involved with Worker's Compensation unrelated to the index knee
- Is involved with health-related litigation
Intra-operative Exclusion Criteria
Subjects will be excluded from the study, if they meet ANY one (1) of the following criteria:
- Has more than 1 chondral lesion requiring treatment
- Requires concomitant procedures (i.e., anterior cruciate ligament repair, high tibial osteotomy), excluding partial medial meniscectomy
- Has a medial meniscal tear not requiring treatment
- Has a medial meniscal tear requiring a procedure other than partial meniscectomy
- Has a lateral meniscal tear requiring treatment
Contacts and Locations| Contact: Heather Neill, RN, CCRP | 512-358-5764 | heather.neill@arthrocare.com |
| United States, Arizona | |
| Tucson Orthopaedic Institute | Recruiting |
| Tucson, Arizona, United States, 85712 | |
| Contact: Jelena Candito, CCRC 520-784-6446 jcandito@tucsonortho.com | |
| Principal Investigator: Nebosja Skrepnik, MD, PhD | |
| Sub-Investigator: Scott Slagis, MD | |
| Sub-Investigator: Lawrence Housman, MD | |
| Sub-Investigator: John J Wild, Jr., MD | |
| United States, Colorado | |
| JDP Medical Research | Recruiting |
| Aurora, Colorado, United States, 80014 | |
| Contact: Julie Knight, RMA, CCRP 303-671-0933 jknight@jdpmedicalresearch.com | |
| Contact: Eve Casiano, CPhT 303-671-0933 ecasiano@jdpmedicalresearch.com | |
| Principal Investigator: John D. Papilion, MD | |
| Sub-Investigator: Cary Motz, MD | |
| United States, Indiana | |
| Orthopaedic Research Foundation, Inc. | Recruiting |
| Greenwood, Indiana, United States, 46143 | |
| Contact: Vicki Snodgrass Miller, CCRC 317-884-5230 vsmiller@orthoindy.com | |
| Principal Investigator: Jack Farr II, MD | |
| United States, Texas | |
| Basin Orthopedic Surgical Specialists | Recruiting |
| Odessa, Texas, United States, 79761 | |
| Contact: Debbie Mossbarger, CCRP 432-853-5567 bossresearch@hotmail.com | |
| Contact: Peggy Ludi, RN, CCRC 432-332-2663 prludirn@gmail.com | |
| Principal Investigator: Steven C. Riley, MD | |
| Sub-Investigator: William Reilly, MD | |
| Principal Investigator: | Jack Farr II, MD | Orthopaedic Research Foundation, Inc. |
More Information
No publications provided
| Responsible Party: | ArthroCare Corporation |
| ClinicalTrials.gov Identifier: | NCT01803880 History of Changes |
| Other Study ID Numbers: | SM-2012-02 |
| Study First Received: | February 15, 2013 |
| Last Updated: | April 24, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by ArthroCare Corporation:
|
Articular cartilage Cartilage lesion Chondral lesion Cartilage defect Radiofrequency Debridement Cartilage Coblation Knee |
Meniscus Partial meniscectomy MR imaging Mechanical debridement Mechanical shaver Torn meniscus Arthroscopic knee surgery Damaged cartilage |
ClinicalTrials.gov processed this record on May 16, 2013